Details for New Drug Application (NDA): 050664
✉ Email this page to a colleague
NDA 050664 describes CEFZIL, which is a drug marketed by Corden Pharma and is included in two NDAs. Additional details are available on the CEFZIL profile page.
The generic ingredient in CEFZIL is cefprozil. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
The generic ingredient in CEFZIL is cefprozil. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the cefprozil profile page.
Summary for 050664
| Tradename: | CEFZIL |
| Applicant: | Corden Pharma |
| Ingredient: | cefprozil |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 23, 1991 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 23, 1991 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
